Ligand Pharmaceuticals Incorporated

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
09/13/94 SC 13D Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Related Documents
HTML PDF 35
RSS